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Shimo-meguro, Meguro-ku, Tokyo 153, Japan hydroxyneomycin B prepared by deamination of neomycin B14). Thus, Id is 1,6"'-dideamino-1,6"'-dihydroxyneomycin B. The structures of la, Ib, Ic and Id are shown in Fig. 1 with those of neomycins and paromomycins.
Str ucture of le
Compound le has been identified as a pseudotrisaccharide by its elemental analysis and 1H and 13C NMR spectra . The 13C carbon signals of le compared well with the corresponding signals of ribostamycin15) (Table 4 ) with exception of three carbons at C-1, C-2 and C-6 which were deshielded by 18.4, 4.0 and 3.9 ppm, respectively, in the spectrum of le. These differences corresponded to those observed between III and neamine. The 13C NMR spectrum of le differed from that of S-11-A (1-deamino-l-hydroxyxylostasin)16) in the chemical shifts of C-2" and C-3". On this basis, le was proved to be 1-deamino-l-hydroxyribostamycin.
The structures of le, ribostamycin and S-11-A are shown in Fig. 2 .
Discussion
The above structural studies demonstrated that inosamycins A, B, C, D and E are novel aminocyclitol antibiotics structurally related to neomycin, paromomycin and ribostamycin containing 2-deoxy-scyllo-inosamine (1-deamino-l-hydroxy-2-deoxystreptamine; HDOS) as the aglycone. 2-Deoxystreptamine (DOS) is the common aglycone of the classical aminocyclitol antibiotics and 1,4-diaminocyclitols have been found as the constituents of newer aminoglycosides. There have been several examples of HDOS-containing aminocyclitol antibiotics, e.g. S-11-A7), SU-1, 2 and 311) and K-144 e and gl8), but they were produced only by mutants (DOS-idiotrophs) of known aminoglycoside-producing strains. Inosamycin represents the first HDOS-containing aminocyclitol antibiotics produced by a naturally occurring microorganism.
The biosynthesis of the aminocyclitol antibiotics was extensively studied by RINEHART, and STROSHANE1D). FUJIWARA et a1.20) recently reported HDOS to be the direct precursor of 2-deoxystreptamine. Production of the HDOS-containing analogues of neomycin, paromomycin and ribostamycin gives further evidence for the biosynthetic route proposed by them. More recently, AUTISSIER et al. isolated 6"'-deamino-6"'-hydroxy analogues of neomycin and paromomycin from a fermentation broth and suggested that 6"'-amination took place at the final step of the biosynthesis of neomycin and paromomycin' . Inosamycin D is an another example of a 6"'-deamino-6"'-hydroxy aminocyclitol antibiotic from the natural origin.
As described in the preceding paper, inosamycin A (1-deamino-l-hydroxyneomycin B) exhibited antibacterial activity comparable to neomycin with acute toxicity significantly lower than neomycin. It is interesting that inosamycin E (1-deamino-l-hydroxyribostamycin) and compound III (1-deamino-1-hydroxyneamine) showed much lower antibacterial activity than the corresponding 1-amino analogues. This might be explained by the fact that at least four basic functions are essential to render substantial activity to this group of aminocyclitol antibiotics, as exemplified by the very weak activity of paromamine relative to neamine. 
